Ticker Details
Olema Pharmaceuticals, Inc.
IPO Date:	November 16, 2020
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$1.93B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.52 | 3.91%
Avg Daily Range (30 D):	$0.77 | 3.01%
Avg Daily Range (90 D):	$0.77 | 3.53%

Institutional Daily Volume
Avg Daily Volume:	.61M
Avg Daily Volume (30 D):	1.14M
Avg Daily Volume (90 D):	2.74M

Trade Size
Avg Trade Size (Sh.):	86
Avg Trade Size (Sh.) (30 D):	67
Avg Trade Size (Sh.) (90 D):	81

Institutional Trades
Total Institutional Trades:	1,068
Avg Institutional Trade:	$1.91M
Avg Institutional Trade (30 D):	$2.76M
Avg Institutional Trade (90 D):	$2.36M
Avg Institutional Trade Volume:	.13M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.47M
Avg Closing Trade (30 D):	$4.01M
Avg Closing Trade (90 D):	$4.03M
Avg Closing Volume:	167.37K

News

Jan 9, 2026 @ 4:08 PM Olema Insider Sells $8 Million in Shares After 300... Source: Jonathan Ponciano

Nov 18, 2025 @ 9:51 PM Olema Oncology Announces Proposed Public Offering ... Source: Courtney O'Konek

Nov 18, 2025 @ 5:01 PM Pharma Bro Martin Shkreli Shorts Olema Pharmaceuti... Source: Erica Kollmann

Oct 18, 2025 @ 7:00 AM Olema Oncology Announces New Data from the Phase 1... Source: Olema Oncology

May 28, 2025 @ 11:00 AM Olema Oncology Announces Palazestrant Dose Selecti... Source: N/A

Financials
	TTM	Q3 2025	Q2 2025
Basic EPS	$-1.76	$-.49	$-.51
Diluted EPS	$-1.76	$-.49	$-.51
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-149.96M	$-42.22M	$-43.78M
Operating Income / Loss	$-165.38M	$-45.88M	$-47.86M
Cost of Revenue
Net Cash Flow	$-.63M	$-17.21M	$1.83M
PE Ratio